The document discusses nervous system dysfunction, including syncope, fatigue, dizziness and vertigo, and neurologic causes of weakness and paralysis. It provides epidemiology, pathophysiology, diagnostic approaches and management strategies for different conditions. Key topics covered include vasovagal and orthostatic syncope, distinguishing peripheral from central causes of dizziness, differentiating upper and lower motor neuron disorders, and evaluating fatigue based on various potential etiologies.
This study examined the physiological responses to progressive reductions in central blood volume from lower body negative pressure (LBNP) in 116 subjects with high tolerance. The subjects were divided into two groups based on their cardiac baroreflex sensitivity (BRS) at the point of presyncope: Group 1 had a BRS over 1.0 and Group 2 had a BRS under 1.0. Contrary to the hypothesis, Group 1 demonstrated lower heart rate, higher stroke volume, less sympathetic nerve activity, and less increase in peripheral vascular resistance compared to Group 2, despite both groups having similar tolerance times, blood pressure levels, and cardiac output at presyncope. This suggests variability in individual physiological strategies for compensating for reduced central blood
Edelman-derived quantification of dyselectrolytemias.
Equation-based monitoring of hyponatremia therapy with a focus on safely and predictably increasing sodium as per guideline advice using a strategy involving desmopressin administration in severe hyponatremias, especially those patients at risk of becoming overcorrectors. Explanation of risk factors responsible for overshooting when correcting hyponatremia. Adrogue-Madias, Barsoum, Nguyen-Kurtz equations are explained and proven to be of help at least conceptually when attempting to have a desmopressin-guided therapy in hyponatremia. All recommendations are done in accordance with European and American guidelines published in 2013 and 2014.
This document presents a case of a 52-year-old female with fluid and electrolyte imbalance. She was admitted for shortness of breath and found to have hyponatremia and pulmonary congestion secondary to heart failure. Laboratory results showed low sodium, high BUN, and abnormal electrolyte ratios. She was diagnosed with hypervolemic hyponatremia and treated with diuretics and fluid restriction, resulting in improved sodium levels over five days. The document then discusses key principles of fluid balance, electrolytes, hypovolemia, and their management.
Copyright 2016 American Medical Association. All rights reserv.docxmelvinjrobinson2199
Copyright 2016 American Medical Association. All rights reserved.
Intensive vs Standard Blood Pressure Control
and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years
A Randomized Clinical Trial
Jeff D. Williamson, MD, MHS; Mark A. Supiano, MD; William B. Applegate, MD, MPH; Dan R. Berlowitz, MD; Ruth C. Campbell, MD, MSPH;
Glenn M. Chertow, MD; Larry J. Fine, MD; William E. Haley, MD; Amret T. Hawfield, MD; Joachim H. Ix, MD, MAS; Dalane W. Kitzman, MD;
John B. Kostis, MD; Marie A. Krousel-Wood, MD; Lenore J. Launer, PhD; Suzanne Oparil, MD; Carlos J. Rodriguez, MD, MPH;
Christianne L. Roumie, MD, MPH; Ronald I. Shorr, MD, MS; Kaycee M. Sink, MD, MAS; Virginia G. Wadley, PhD; Paul K. Whelton, MD;
Jeffrey Whittle, MD; Nancy F. Woolard; Jackson T. Wright Jr, MD, PhD; Nicholas M. Pajewski, PhD; for the SPRINT Research Group
IMPORTANCE The appropriate treatment target for systolic blood pressure (SBP) in older
patients with hypertension remains uncertain.
OBJECTIVE To evaluate the effects of intensive (<120 mm Hg) compared with standard
(<140 mm Hg) SBP targets in persons aged 75 years or older with hypertension
but without diabetes.
DESIGN, SETTING, AND PARTICIPANTS A multicenter, randomized clinical trial of patients aged
75 years or older who participated in the Systolic Blood Pressure Intervention Trial (SPRINT).
Recruitment began on October 20, 2010, and follow-up ended on August 20, 2015.
INTERVENTIONS Participants were randomized to an SBP target of less than 120 mm Hg
(intensive treatment group, n = 1317) or an SBP target of less than 140 mm Hg (standard
treatment group, n = 1319).
MAIN OUTCOMES AND MEASURES The primary cardiovascular disease outcome was a
composite of nonfatal myocardial infarction, acute coronary syndrome not resulting in a
myocardial infarction, nonfatal stroke, nonfatal acute decompensated heart failure, and death
from cardiovascular causes. All-cause mortality was a secondary outcome.
RESULTS Among 2636 participants (mean age, 79.9 years; 37.9% women), 2510 (95.2%)
provided complete follow-up data. At a median follow-up of 3.14 years, there was a
significantly lower rate of the primary composite outcome (102 events in the intensive
treatment group vs 148 events in the standard treatment group; hazard ratio [HR], 0.66
[95% CI, 0.51-0.85]) and all-cause mortality (73 deaths vs 107 deaths, respectively; HR, 0.67
[95% CI, 0.49-0.91]). The overall rate of serious adverse events was not different between
treatment groups (48.4% in the intensive treatment group vs 48.3% in the standard
treatment group; HR, 0.99 [95% CI, 0.89-1.11]). Absolute rates of hypotension were 2.4% in
the intensive treatment group vs 1.4% in the standard treatment group (HR, 1.71 [95% CI,
0.97-3.09]), 3.0% vs 2.4%, respectively, for syncope (HR, 1.23 [95% CI, 0.76-2.00]), 4.0% vs
2.7% for electrolyte abnormalities (HR, 1.51 [95% CI, 0.99-2.33]), 5.5% vs 4.0% for acute
kidney injury (HR, 1.41 [95% CI, 0.98-2.04]), and 4.9% vs 5.5% for inj.
Copyright 2016 American Medical Association. All rights reserv.docxbobbywlane695641
Copyright 2016 American Medical Association. All rights reserved.
Intensive vs Standard Blood Pressure Control
and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years
A Randomized Clinical Trial
Jeff D. Williamson, MD, MHS; Mark A. Supiano, MD; William B. Applegate, MD, MPH; Dan R. Berlowitz, MD; Ruth C. Campbell, MD, MSPH;
Glenn M. Chertow, MD; Larry J. Fine, MD; William E. Haley, MD; Amret T. Hawfield, MD; Joachim H. Ix, MD, MAS; Dalane W. Kitzman, MD;
John B. Kostis, MD; Marie A. Krousel-Wood, MD; Lenore J. Launer, PhD; Suzanne Oparil, MD; Carlos J. Rodriguez, MD, MPH;
Christianne L. Roumie, MD, MPH; Ronald I. Shorr, MD, MS; Kaycee M. Sink, MD, MAS; Virginia G. Wadley, PhD; Paul K. Whelton, MD;
Jeffrey Whittle, MD; Nancy F. Woolard; Jackson T. Wright Jr, MD, PhD; Nicholas M. Pajewski, PhD; for the SPRINT Research Group
IMPORTANCE The appropriate treatment target for systolic blood pressure (SBP) in older
patients with hypertension remains uncertain.
OBJECTIVE To evaluate the effects of intensive (<120 mm Hg) compared with standard
(<140 mm Hg) SBP targets in persons aged 75 years or older with hypertension
but without diabetes.
DESIGN, SETTING, AND PARTICIPANTS A multicenter, randomized clinical trial of patients aged
75 years or older who participated in the Systolic Blood Pressure Intervention Trial (SPRINT).
Recruitment began on October 20, 2010, and follow-up ended on August 20, 2015.
INTERVENTIONS Participants were randomized to an SBP target of less than 120 mm Hg
(intensive treatment group, n = 1317) or an SBP target of less than 140 mm Hg (standard
treatment group, n = 1319).
MAIN OUTCOMES AND MEASURES The primary cardiovascular disease outcome was a
composite of nonfatal myocardial infarction, acute coronary syndrome not resulting in a
myocardial infarction, nonfatal stroke, nonfatal acute decompensated heart failure, and death
from cardiovascular causes. All-cause mortality was a secondary outcome.
RESULTS Among 2636 participants (mean age, 79.9 years; 37.9% women), 2510 (95.2%)
provided complete follow-up data. At a median follow-up of 3.14 years, there was a
significantly lower rate of the primary composite outcome (102 events in the intensive
treatment group vs 148 events in the standard treatment group; hazard ratio [HR], 0.66
[95% CI, 0.51-0.85]) and all-cause mortality (73 deaths vs 107 deaths, respectively; HR, 0.67
[95% CI, 0.49-0.91]). The overall rate of serious adverse events was not different between
treatment groups (48.4% in the intensive treatment group vs 48.3% in the standard
treatment group; HR, 0.99 [95% CI, 0.89-1.11]). Absolute rates of hypotension were 2.4% in
the intensive treatment group vs 1.4% in the standard treatment group (HR, 1.71 [95% CI,
0.97-3.09]), 3.0% vs 2.4%, respectively, for syncope (HR, 1.23 [95% CI, 0.76-2.00]), 4.0% vs
2.7% for electrolyte abnormalities (HR, 1.51 [95% CI, 0.99-2.33]), 5.5% vs 4.0% for acute
kidney injury (HR, 1.41 [95% CI, 0.98-2.04]), and 4.9% vs 5.5% for inj.
This study examined the relationship between a "triple low" state of low mean arterial pressure, low bispectral index, and low minimum alveolar concentration of volatile anesthesia with hospital length of stay and 30-day mortality in 24,120 patients. The study found that the occurrence of a triple low state was associated with significantly increased length of stay and mortality risk compared to patients without a triple low. Mortality risk increased progressively with longer durations spent in the triple low state.
This document discusses electrolyte abnormalities including hyponatremia, hypernatremia, and hypochloremia. It begins by defining each condition based on serum sodium and chloride levels. It then discusses the etiologies, clinical presentations, diagnosis, and treatment of each condition, citing several academic references. The document also includes classifications of hyponatremia and formulas relevant to disorders of sodium. Overall, the document provides an overview of key electrolyte imbalances and their management.
Cardiac risk evaluation: searching for the vulnerable patient FELIX NUNURA
The document discusses screening patients for cardiovascular risk factors and disease. It outlines various risk assessment tools like the Framingham Risk Score and SCORE that estimate risk based on factors like age, cholesterol levels, blood pressure, smoking status. It discusses limitations of risk factor-based screening and emphasizes the importance of directly measuring subclinical disease using tests like coronary artery calcium scoring and carotid intima-media thickness to identify vulnerable patients. The document advocates screening for and treating the underlying atherosclerotic disease rather than just risk factors to improve prevention outcomes.
This study examined the physiological responses to progressive reductions in central blood volume from lower body negative pressure (LBNP) in 116 subjects with high tolerance. The subjects were divided into two groups based on their cardiac baroreflex sensitivity (BRS) at the point of presyncope: Group 1 had a BRS over 1.0 and Group 2 had a BRS under 1.0. Contrary to the hypothesis, Group 1 demonstrated lower heart rate, higher stroke volume, less sympathetic nerve activity, and less increase in peripheral vascular resistance compared to Group 2, despite both groups having similar tolerance times, blood pressure levels, and cardiac output at presyncope. This suggests variability in individual physiological strategies for compensating for reduced central blood
Edelman-derived quantification of dyselectrolytemias.
Equation-based monitoring of hyponatremia therapy with a focus on safely and predictably increasing sodium as per guideline advice using a strategy involving desmopressin administration in severe hyponatremias, especially those patients at risk of becoming overcorrectors. Explanation of risk factors responsible for overshooting when correcting hyponatremia. Adrogue-Madias, Barsoum, Nguyen-Kurtz equations are explained and proven to be of help at least conceptually when attempting to have a desmopressin-guided therapy in hyponatremia. All recommendations are done in accordance with European and American guidelines published in 2013 and 2014.
This document presents a case of a 52-year-old female with fluid and electrolyte imbalance. She was admitted for shortness of breath and found to have hyponatremia and pulmonary congestion secondary to heart failure. Laboratory results showed low sodium, high BUN, and abnormal electrolyte ratios. She was diagnosed with hypervolemic hyponatremia and treated with diuretics and fluid restriction, resulting in improved sodium levels over five days. The document then discusses key principles of fluid balance, electrolytes, hypovolemia, and their management.
Copyright 2016 American Medical Association. All rights reserv.docxmelvinjrobinson2199
Copyright 2016 American Medical Association. All rights reserved.
Intensive vs Standard Blood Pressure Control
and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years
A Randomized Clinical Trial
Jeff D. Williamson, MD, MHS; Mark A. Supiano, MD; William B. Applegate, MD, MPH; Dan R. Berlowitz, MD; Ruth C. Campbell, MD, MSPH;
Glenn M. Chertow, MD; Larry J. Fine, MD; William E. Haley, MD; Amret T. Hawfield, MD; Joachim H. Ix, MD, MAS; Dalane W. Kitzman, MD;
John B. Kostis, MD; Marie A. Krousel-Wood, MD; Lenore J. Launer, PhD; Suzanne Oparil, MD; Carlos J. Rodriguez, MD, MPH;
Christianne L. Roumie, MD, MPH; Ronald I. Shorr, MD, MS; Kaycee M. Sink, MD, MAS; Virginia G. Wadley, PhD; Paul K. Whelton, MD;
Jeffrey Whittle, MD; Nancy F. Woolard; Jackson T. Wright Jr, MD, PhD; Nicholas M. Pajewski, PhD; for the SPRINT Research Group
IMPORTANCE The appropriate treatment target for systolic blood pressure (SBP) in older
patients with hypertension remains uncertain.
OBJECTIVE To evaluate the effects of intensive (<120 mm Hg) compared with standard
(<140 mm Hg) SBP targets in persons aged 75 years or older with hypertension
but without diabetes.
DESIGN, SETTING, AND PARTICIPANTS A multicenter, randomized clinical trial of patients aged
75 years or older who participated in the Systolic Blood Pressure Intervention Trial (SPRINT).
Recruitment began on October 20, 2010, and follow-up ended on August 20, 2015.
INTERVENTIONS Participants were randomized to an SBP target of less than 120 mm Hg
(intensive treatment group, n = 1317) or an SBP target of less than 140 mm Hg (standard
treatment group, n = 1319).
MAIN OUTCOMES AND MEASURES The primary cardiovascular disease outcome was a
composite of nonfatal myocardial infarction, acute coronary syndrome not resulting in a
myocardial infarction, nonfatal stroke, nonfatal acute decompensated heart failure, and death
from cardiovascular causes. All-cause mortality was a secondary outcome.
RESULTS Among 2636 participants (mean age, 79.9 years; 37.9% women), 2510 (95.2%)
provided complete follow-up data. At a median follow-up of 3.14 years, there was a
significantly lower rate of the primary composite outcome (102 events in the intensive
treatment group vs 148 events in the standard treatment group; hazard ratio [HR], 0.66
[95% CI, 0.51-0.85]) and all-cause mortality (73 deaths vs 107 deaths, respectively; HR, 0.67
[95% CI, 0.49-0.91]). The overall rate of serious adverse events was not different between
treatment groups (48.4% in the intensive treatment group vs 48.3% in the standard
treatment group; HR, 0.99 [95% CI, 0.89-1.11]). Absolute rates of hypotension were 2.4% in
the intensive treatment group vs 1.4% in the standard treatment group (HR, 1.71 [95% CI,
0.97-3.09]), 3.0% vs 2.4%, respectively, for syncope (HR, 1.23 [95% CI, 0.76-2.00]), 4.0% vs
2.7% for electrolyte abnormalities (HR, 1.51 [95% CI, 0.99-2.33]), 5.5% vs 4.0% for acute
kidney injury (HR, 1.41 [95% CI, 0.98-2.04]), and 4.9% vs 5.5% for inj.
Copyright 2016 American Medical Association. All rights reserv.docxbobbywlane695641
Copyright 2016 American Medical Association. All rights reserved.
Intensive vs Standard Blood Pressure Control
and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years
A Randomized Clinical Trial
Jeff D. Williamson, MD, MHS; Mark A. Supiano, MD; William B. Applegate, MD, MPH; Dan R. Berlowitz, MD; Ruth C. Campbell, MD, MSPH;
Glenn M. Chertow, MD; Larry J. Fine, MD; William E. Haley, MD; Amret T. Hawfield, MD; Joachim H. Ix, MD, MAS; Dalane W. Kitzman, MD;
John B. Kostis, MD; Marie A. Krousel-Wood, MD; Lenore J. Launer, PhD; Suzanne Oparil, MD; Carlos J. Rodriguez, MD, MPH;
Christianne L. Roumie, MD, MPH; Ronald I. Shorr, MD, MS; Kaycee M. Sink, MD, MAS; Virginia G. Wadley, PhD; Paul K. Whelton, MD;
Jeffrey Whittle, MD; Nancy F. Woolard; Jackson T. Wright Jr, MD, PhD; Nicholas M. Pajewski, PhD; for the SPRINT Research Group
IMPORTANCE The appropriate treatment target for systolic blood pressure (SBP) in older
patients with hypertension remains uncertain.
OBJECTIVE To evaluate the effects of intensive (<120 mm Hg) compared with standard
(<140 mm Hg) SBP targets in persons aged 75 years or older with hypertension
but without diabetes.
DESIGN, SETTING, AND PARTICIPANTS A multicenter, randomized clinical trial of patients aged
75 years or older who participated in the Systolic Blood Pressure Intervention Trial (SPRINT).
Recruitment began on October 20, 2010, and follow-up ended on August 20, 2015.
INTERVENTIONS Participants were randomized to an SBP target of less than 120 mm Hg
(intensive treatment group, n = 1317) or an SBP target of less than 140 mm Hg (standard
treatment group, n = 1319).
MAIN OUTCOMES AND MEASURES The primary cardiovascular disease outcome was a
composite of nonfatal myocardial infarction, acute coronary syndrome not resulting in a
myocardial infarction, nonfatal stroke, nonfatal acute decompensated heart failure, and death
from cardiovascular causes. All-cause mortality was a secondary outcome.
RESULTS Among 2636 participants (mean age, 79.9 years; 37.9% women), 2510 (95.2%)
provided complete follow-up data. At a median follow-up of 3.14 years, there was a
significantly lower rate of the primary composite outcome (102 events in the intensive
treatment group vs 148 events in the standard treatment group; hazard ratio [HR], 0.66
[95% CI, 0.51-0.85]) and all-cause mortality (73 deaths vs 107 deaths, respectively; HR, 0.67
[95% CI, 0.49-0.91]). The overall rate of serious adverse events was not different between
treatment groups (48.4% in the intensive treatment group vs 48.3% in the standard
treatment group; HR, 0.99 [95% CI, 0.89-1.11]). Absolute rates of hypotension were 2.4% in
the intensive treatment group vs 1.4% in the standard treatment group (HR, 1.71 [95% CI,
0.97-3.09]), 3.0% vs 2.4%, respectively, for syncope (HR, 1.23 [95% CI, 0.76-2.00]), 4.0% vs
2.7% for electrolyte abnormalities (HR, 1.51 [95% CI, 0.99-2.33]), 5.5% vs 4.0% for acute
kidney injury (HR, 1.41 [95% CI, 0.98-2.04]), and 4.9% vs 5.5% for inj.
This study examined the relationship between a "triple low" state of low mean arterial pressure, low bispectral index, and low minimum alveolar concentration of volatile anesthesia with hospital length of stay and 30-day mortality in 24,120 patients. The study found that the occurrence of a triple low state was associated with significantly increased length of stay and mortality risk compared to patients without a triple low. Mortality risk increased progressively with longer durations spent in the triple low state.
This document discusses electrolyte abnormalities including hyponatremia, hypernatremia, and hypochloremia. It begins by defining each condition based on serum sodium and chloride levels. It then discusses the etiologies, clinical presentations, diagnosis, and treatment of each condition, citing several academic references. The document also includes classifications of hyponatremia and formulas relevant to disorders of sodium. Overall, the document provides an overview of key electrolyte imbalances and their management.
Cardiac risk evaluation: searching for the vulnerable patient FELIX NUNURA
The document discusses screening patients for cardiovascular risk factors and disease. It outlines various risk assessment tools like the Framingham Risk Score and SCORE that estimate risk based on factors like age, cholesterol levels, blood pressure, smoking status. It discusses limitations of risk factor-based screening and emphasizes the importance of directly measuring subclinical disease using tests like coronary artery calcium scoring and carotid intima-media thickness to identify vulnerable patients. The document advocates screening for and treating the underlying atherosclerotic disease rather than just risk factors to improve prevention outcomes.
This document discusses several conditions that can mimic or be misdiagnosed as bronchial asthma, including vocal cord dysfunction, cardiac asthma, gastroesophageal reflux disease, postnasal drip syndrome, and reactive airways dysfunction syndrome. It provides details on the clinical presentation and diagnostic criteria for each condition. The key points are that these "asthma mimics" are commonly treated as asthma, leading to overuse of medications and poor outcomes for patients, and a high index of suspicion for alternative diagnoses should be considered for patients who do not respond to typical asthma treatment. Diagnosis of the mimics often requires specialized testing like laryngoscopy.
This document summarizes a study comparing clinical characteristics of hypertensive intracerebral hemorrhage (ICH) in young patients versus older patients. The study found that young patients had higher blood pressures, smaller hemorrhage volumes, lower rates of ventricular extensions, and a different distribution pattern of ICH locations. Mortality was lower in young patients but they had more disabling outcomes. The findings suggest there are age-related differences in the pathogenesis of hypertensive ICH.
please respond to each discussion post with apa references for.docxbkbk37
The document summarizes the pathophysiology, clinical manifestations, evaluation, and treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) and Diabetes Insipidus (DI). SIADH is caused by excessive secretion of antidiuretic hormone leading to water retention and hyponatremia. DI results from a lack of antidiuretic hormone causing excessive urination and thirst. Both conditions cause opposite effects due to differences in antidiuretic hormone levels. Evaluation involves laboratory tests and treatment focuses on correcting the underlying causes and sodium levels in the case of SIADH or replacing antidiuretic hormone for DI.
Hypertension, or high blood pressure, is a growing global health concern that disproportionately affects minority populations like African Americans. The literature review examined 15 research articles on managing hypertension in these high-risk groups. Key findings included: (1) multiple-drug regimens are often needed to control blood pressure; (2) lifestyle modifications can help reduce cardiovascular events; and (3) improving patient education and adherence through culturally-appropriate strategies may enhance health outcomes. Overall, the studies emphasized the importance of early detection, treatment, and prevention to reduce hypertension's harmful effects.
This document discusses hyperhidrosis (excessive sweating), covering its epidemiology, etiology, pathophysiology, diagnosis, and treatment. It notes that hyperhidrosis is caused by overstimulation of cholinergic receptors, and can have physical and social impacts. The diagnosis involves examining family history and sweat production; and treatments include topical anticholinergics, oral medications, iontophoresis, botulinum toxin injections, and sympathectomy for severe cases. The summary emphasizes that hyperhidrosis affects patients' physical and psychological health as well as their quality of life.
Management of headaches - an evidence based approach. Presented by Dr. George Koshy Vilanilam M.B.B.S as a part of research topic presentation for clinical rotation, July 2017
Holmes tremor (HT) is a resting and intention tremor that typically develops months after a central nervous system injury. It is thought to involve damage to dopaminergic and cerebellar pathways. Common causes include vascular lesions. Patients often present with hemiparesis, ataxia, and other neurological signs. Lesions are usually found in the thalamus or midbrain. Effective treatments include functional neurosurgery, levodopa, or deep brain stimulation.
This document summarizes a literature review on the effect of hemiparesis on blood pressure measurements. Several studies found that blood pressure was often higher in the hemiparetic arm compared to the non-affected arm, especially if the hemiparetic arm had increased muscle tone. However, other studies found blood pressure could also be lower in the hemiparetic arm, especially if it was flaccid. The literature review concluded that the best practice is to measure blood pressure in both arms to identify any interarm differences, as blood pressure can be either higher or lower in the hemiparetic arm. It recommends reminding nurses to measure blood pressure in both arms for stroke patients.
This document defines and describes different types of movement disorders including chorea, athetosis, and ballism. It discusses the etiology and characteristics of various forms of chorea including vascular chorea, autoimmune chorea, drug-induced chorea, metabolic chorea, and infectious chorea. The roles of structures like the globus pallidus and subthalamic nucleus in causing hyperkinetic movements are mentioned. Treatment options vary depending on the underlying cause but may include medications, surgery, or management of any precipitating conditions.
This document summarizes the management of oral surgery patients with thrombocytopenia. It begins with an introduction on the challenges of treating patients with bleeding disorders. It then covers basic platelet physiology, describing their production in bone marrow and role in hemostasis. The main types of platelet disorders are outlined as quantitative (too few platelets) and qualitative (dysfunction). Specific causes, diagnoses, and treatment approaches for different platelet disorders are discussed. Three case studies are also referenced to illustrate management of thrombocytopenic patients undergoing oral surgery.
This document provides an overview of hypertrophic cardiomyopathy (HCM). It begins with definitions of cardiomyopathy and HCM. It then discusses the historical perspective, genetic basis, morphology, pathophysiology, clinical features, diagnosis, and management of HCM. Some key points include:
- HCM is a genetic heart condition characterized by unexplained thickening of the heart muscle. It is the most common cause of sudden cardiac death in young people.
- The genetic basis involves mutations in genes encoding sarcomere proteins. This leads to impaired relaxation and increased calcium sensitivity of the heart muscle.
- Morphologically, HCM involves asymmetric left ventricular hypertrophy and abnormalities of the mitral valve apparatus. Hist
1. Bradycardia is a common finding in anorexia nervosa (AN), affecting 41.3% of patients in one study.
2. Prolonged QT interval is also seen in AN and is linked to reduced heart rate, though the link is weaker when corrected for heart rate.
3. All-cause mortality is increased in AN, including from cardiac arrest unrelated to QT interval duration. Additional complications like reduced cardiac mass and valve issues have been observed in larger population studies.
- Dystonia is estimated to affect 16.4 per 100,000 people worldwide. A study in India found a prevalence of 43.91 per 100,000 for primary dystonias.
- Primary dystonias are more common than secondary dystonias. Common causes of secondary dystonia include infections, hypoxia, trauma, and kernicterus.
- Dystonia presents with sustained muscle contractions causing abnormal postures or repetitive movements. It can be initiated or worsened by voluntary actions and often involves overflow to nearby muscles.
This document provides an overview and summary of Pulse Dynamics technology, which analyzes arterial pulse waveforms to noninvasively measure hemodynamic parameters like arterial compliance, peripheral resistance, and left ventricular contractility. It discusses clinical studies that have validated the use of Pulse Dynamics to study hypertension, cardiovascular risk factors, heart disease, renal disease, and more. The document also outlines the physics behind Pulse Dynamics methodology and provides sample reports and comments from physicians on their experience using Pulse Dynamics in clinical research and patient care.
Nanoparticle based drug delivery for sinusitis Arun kumar
Sinusitis is inflammation of the sinuses caused by infection, allergies, or structural issues. Common symptoms include facial pain and congestion. It can be acute (less than 4 weeks), recurrent acute (4+ episodes in a year), subacute (4-12 weeks), or chronic (over 12 weeks). Diagnosis is usually clinical but imaging may be used for complicated cases. Treatment depends on type but may include antibiotics, nasal irrigation, or surgery. New developments include using nanoparticles to deliver antibiotics directly to the sinuses.
Negative emotions and health: Why do we keep stalking bears.ehpsJames Coyne
This document discusses the tendency of researchers to make spurious claims linking negative emotions to health outcomes. For over 50 years, researchers have claimed to find a modifiable connection between negative emotion and morbidity/mortality, but these claims often lead to embarrassment after being disconfirmed. The document argues that many studies actually find only uninformative risk markers rather than true modifiable risk factors. It warns against continuing to make premature or exaggerated claims without ruling out alternative explanations like residual confounding.
Severe Hyponatremia, SIADH, and Pericardiac Effusion as Initial Presenting Fe...Jayanth Hiremagalur
A 56-year-old female presented with headache, dysarthria, and unsteady gait. Imaging revealed a moderate to large pericardial effusion. Labs showed hyponatremia consistent with SIADH. A pericardial window drained fluid and symptoms improved. Further imaging found metastatic non-Hodgkin's lymphoma to the pericardium and lung, explaining the presentation. The patient's citalopram use and pericardial effusion both likely contributed to her SIADH. Management included fluid restriction, hypertonic saline, and pericardial drainage.
This literature review summarizes the clinical characteristics of myocardial stunning (neurogenic stunned myocardium or NSM) seen in patients after acute ischemic stroke. The review identified 7 case reports/series describing a total of 13 patients with NSM following stroke. Key findings include that NSM after stroke was more common in older females, with involvement of the left ventricle apex. Less than half of cases involved the insular cortex. Troponin levels and left ventricular dysfunction were typically mild. Most patients showed significant left ventricular recovery within 4 weeks, indicating a generally favorable prognosis. However, larger prospective studies are still needed.
This document discusses several conditions that can mimic or be misdiagnosed as bronchial asthma, including vocal cord dysfunction, cardiac asthma, gastroesophageal reflux disease, postnasal drip syndrome, and reactive airways dysfunction syndrome. It provides details on the clinical presentation and diagnostic criteria for each condition. The key points are that these "asthma mimics" are commonly treated as asthma, leading to overuse of medications and poor outcomes for patients, and a high index of suspicion for alternative diagnoses should be considered for patients who do not respond to typical asthma treatment. Diagnosis of the mimics often requires specialized testing like laryngoscopy.
This document summarizes a study comparing clinical characteristics of hypertensive intracerebral hemorrhage (ICH) in young patients versus older patients. The study found that young patients had higher blood pressures, smaller hemorrhage volumes, lower rates of ventricular extensions, and a different distribution pattern of ICH locations. Mortality was lower in young patients but they had more disabling outcomes. The findings suggest there are age-related differences in the pathogenesis of hypertensive ICH.
please respond to each discussion post with apa references for.docxbkbk37
The document summarizes the pathophysiology, clinical manifestations, evaluation, and treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) and Diabetes Insipidus (DI). SIADH is caused by excessive secretion of antidiuretic hormone leading to water retention and hyponatremia. DI results from a lack of antidiuretic hormone causing excessive urination and thirst. Both conditions cause opposite effects due to differences in antidiuretic hormone levels. Evaluation involves laboratory tests and treatment focuses on correcting the underlying causes and sodium levels in the case of SIADH or replacing antidiuretic hormone for DI.
Hypertension, or high blood pressure, is a growing global health concern that disproportionately affects minority populations like African Americans. The literature review examined 15 research articles on managing hypertension in these high-risk groups. Key findings included: (1) multiple-drug regimens are often needed to control blood pressure; (2) lifestyle modifications can help reduce cardiovascular events; and (3) improving patient education and adherence through culturally-appropriate strategies may enhance health outcomes. Overall, the studies emphasized the importance of early detection, treatment, and prevention to reduce hypertension's harmful effects.
This document discusses hyperhidrosis (excessive sweating), covering its epidemiology, etiology, pathophysiology, diagnosis, and treatment. It notes that hyperhidrosis is caused by overstimulation of cholinergic receptors, and can have physical and social impacts. The diagnosis involves examining family history and sweat production; and treatments include topical anticholinergics, oral medications, iontophoresis, botulinum toxin injections, and sympathectomy for severe cases. The summary emphasizes that hyperhidrosis affects patients' physical and psychological health as well as their quality of life.
Management of headaches - an evidence based approach. Presented by Dr. George Koshy Vilanilam M.B.B.S as a part of research topic presentation for clinical rotation, July 2017
Holmes tremor (HT) is a resting and intention tremor that typically develops months after a central nervous system injury. It is thought to involve damage to dopaminergic and cerebellar pathways. Common causes include vascular lesions. Patients often present with hemiparesis, ataxia, and other neurological signs. Lesions are usually found in the thalamus or midbrain. Effective treatments include functional neurosurgery, levodopa, or deep brain stimulation.
This document summarizes a literature review on the effect of hemiparesis on blood pressure measurements. Several studies found that blood pressure was often higher in the hemiparetic arm compared to the non-affected arm, especially if the hemiparetic arm had increased muscle tone. However, other studies found blood pressure could also be lower in the hemiparetic arm, especially if it was flaccid. The literature review concluded that the best practice is to measure blood pressure in both arms to identify any interarm differences, as blood pressure can be either higher or lower in the hemiparetic arm. It recommends reminding nurses to measure blood pressure in both arms for stroke patients.
This document defines and describes different types of movement disorders including chorea, athetosis, and ballism. It discusses the etiology and characteristics of various forms of chorea including vascular chorea, autoimmune chorea, drug-induced chorea, metabolic chorea, and infectious chorea. The roles of structures like the globus pallidus and subthalamic nucleus in causing hyperkinetic movements are mentioned. Treatment options vary depending on the underlying cause but may include medications, surgery, or management of any precipitating conditions.
This document summarizes the management of oral surgery patients with thrombocytopenia. It begins with an introduction on the challenges of treating patients with bleeding disorders. It then covers basic platelet physiology, describing their production in bone marrow and role in hemostasis. The main types of platelet disorders are outlined as quantitative (too few platelets) and qualitative (dysfunction). Specific causes, diagnoses, and treatment approaches for different platelet disorders are discussed. Three case studies are also referenced to illustrate management of thrombocytopenic patients undergoing oral surgery.
This document provides an overview of hypertrophic cardiomyopathy (HCM). It begins with definitions of cardiomyopathy and HCM. It then discusses the historical perspective, genetic basis, morphology, pathophysiology, clinical features, diagnosis, and management of HCM. Some key points include:
- HCM is a genetic heart condition characterized by unexplained thickening of the heart muscle. It is the most common cause of sudden cardiac death in young people.
- The genetic basis involves mutations in genes encoding sarcomere proteins. This leads to impaired relaxation and increased calcium sensitivity of the heart muscle.
- Morphologically, HCM involves asymmetric left ventricular hypertrophy and abnormalities of the mitral valve apparatus. Hist
1. Bradycardia is a common finding in anorexia nervosa (AN), affecting 41.3% of patients in one study.
2. Prolonged QT interval is also seen in AN and is linked to reduced heart rate, though the link is weaker when corrected for heart rate.
3. All-cause mortality is increased in AN, including from cardiac arrest unrelated to QT interval duration. Additional complications like reduced cardiac mass and valve issues have been observed in larger population studies.
- Dystonia is estimated to affect 16.4 per 100,000 people worldwide. A study in India found a prevalence of 43.91 per 100,000 for primary dystonias.
- Primary dystonias are more common than secondary dystonias. Common causes of secondary dystonia include infections, hypoxia, trauma, and kernicterus.
- Dystonia presents with sustained muscle contractions causing abnormal postures or repetitive movements. It can be initiated or worsened by voluntary actions and often involves overflow to nearby muscles.
This document provides an overview and summary of Pulse Dynamics technology, which analyzes arterial pulse waveforms to noninvasively measure hemodynamic parameters like arterial compliance, peripheral resistance, and left ventricular contractility. It discusses clinical studies that have validated the use of Pulse Dynamics to study hypertension, cardiovascular risk factors, heart disease, renal disease, and more. The document also outlines the physics behind Pulse Dynamics methodology and provides sample reports and comments from physicians on their experience using Pulse Dynamics in clinical research and patient care.
Nanoparticle based drug delivery for sinusitis Arun kumar
Sinusitis is inflammation of the sinuses caused by infection, allergies, or structural issues. Common symptoms include facial pain and congestion. It can be acute (less than 4 weeks), recurrent acute (4+ episodes in a year), subacute (4-12 weeks), or chronic (over 12 weeks). Diagnosis is usually clinical but imaging may be used for complicated cases. Treatment depends on type but may include antibiotics, nasal irrigation, or surgery. New developments include using nanoparticles to deliver antibiotics directly to the sinuses.
Negative emotions and health: Why do we keep stalking bears.ehpsJames Coyne
This document discusses the tendency of researchers to make spurious claims linking negative emotions to health outcomes. For over 50 years, researchers have claimed to find a modifiable connection between negative emotion and morbidity/mortality, but these claims often lead to embarrassment after being disconfirmed. The document argues that many studies actually find only uninformative risk markers rather than true modifiable risk factors. It warns against continuing to make premature or exaggerated claims without ruling out alternative explanations like residual confounding.
Severe Hyponatremia, SIADH, and Pericardiac Effusion as Initial Presenting Fe...Jayanth Hiremagalur
A 56-year-old female presented with headache, dysarthria, and unsteady gait. Imaging revealed a moderate to large pericardial effusion. Labs showed hyponatremia consistent with SIADH. A pericardial window drained fluid and symptoms improved. Further imaging found metastatic non-Hodgkin's lymphoma to the pericardium and lung, explaining the presentation. The patient's citalopram use and pericardial effusion both likely contributed to her SIADH. Management included fluid restriction, hypertonic saline, and pericardial drainage.
This literature review summarizes the clinical characteristics of myocardial stunning (neurogenic stunned myocardium or NSM) seen in patients after acute ischemic stroke. The review identified 7 case reports/series describing a total of 13 patients with NSM following stroke. Key findings include that NSM after stroke was more common in older females, with involvement of the left ventricle apex. Less than half of cases involved the insular cortex. Troponin levels and left ventricular dysfunction were typically mild. Most patients showed significant left ventricular recovery within 4 weeks, indicating a generally favorable prognosis. However, larger prospective studies are still needed.
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)blessyjannu21
Neurological system includes brain and spinal cord. It plays an important role in functioning of our body. Encephalitis is the inflammation of the brain. Causes include viral infections, infections from insect bites or an autoimmune reaction that affects the brain. It can be life-threatening or cause long-term complications. Treatment varies, but most people require hospitalization so they can receive intensive treatment, including life support.
MBC Support Group for Black Women – Insights in Genetic Testing.pdfbkling
Christina Spears, breast cancer genetic counselor at the Ohio State University Comprehensive Cancer Center, joined us for the MBC Support Group for Black Women to discuss the importance of genetic testing in communities of color and answer pressing questions.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
The best massage spa Ajman is Chandrima Spa Ajman, which was founded in 2023 and is exclusively for men 24 hours a day. As of right now, our parent firm has been providing massage services to over 50,000+ clients in Ajman for the past 10 years. It has about 8+ branches. This demonstrates that Chandrima Spa Ajman is among the most reasonably priced spas in Ajman and the ideal place to unwind and rejuvenate. We provide a wide range of Spa massage treatments, including Indian, Pakistani, Kerala, Malayali, and body-to-body massages. Numerous massage techniques are available, including deep tissue, Swedish, Thai, Russian, and hot stone massages. Our massage therapists produce genuinely unique treatments that generate a revitalized sense of inner serenely by fusing modern techniques, the cleanest natural substances, and traditional holistic therapists.
Healthy Eating Habits:
Understanding Nutrition Labels: Teaches how to read and interpret food labels, focusing on serving sizes, calorie intake, and nutrients to limit or include.
Tips for Healthy Eating: Offers practical advice such as incorporating a variety of foods, practicing moderation, staying hydrated, and eating mindfully.
Benefits of Regular Exercise:
Physical Benefits: Discusses how exercise aids in weight management, muscle and bone health, cardiovascular health, and flexibility.
Mental Benefits: Explains the psychological advantages, including stress reduction, improved mood, and better sleep.
Tips for Staying Active:
Encourages consistency, variety in exercises, setting realistic goals, and finding enjoyable activities to maintain motivation.
Maintaining a Balanced Lifestyle:
Integrating Nutrition and Exercise: Suggests meal planning and incorporating physical activity into daily routines.
Monitoring Progress: Recommends tracking food intake and exercise, regular health check-ups, and provides tips for achieving balance, such as getting sufficient sleep, managing stress, and staying socially active.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareDr. David Greene Arizona
Explore the groundbreaking work of Dr. David Greene, a pioneer in regenerative medicine, who is revolutionizing the field of cardiology through stem cell therapy in Arizona. This ppt delves into how Dr. Greene's innovative approach is providing non-surgical, effective treatments for heart disease, using the body's own cells to repair heart damage and improve patient outcomes. Learn about the science behind stem cell therapy, its benefits over traditional cardiac surgeries, and the promising future it holds for modern medicine. Join us as we uncover how Dr. Greene's commitment to stem cell research and therapy is setting new standards in healthcare and offering new hope to cardiac patients.
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
2. OBJECTIVES
• To be able to identify and distinguish different types of nervous system dysfunction
• To know the pathophysiology behind each condition
• To establish a definitive approach to management
5. EPIDEMIOLOGY AND NATURAL HISTORY
Cardiac (structural)
Neurally mediated /
Vasovagal syncope
35% cumulative
incidence
Higher mortality
10% cardiac cause
Women > Men
Genetic basis
Peak 10-30 y/o, median 15 y/o
The likelihood of hospitalization and mortality risk are higher in older adults.
/
Jameson, L., Fauci, A., Kasper, D., Hauser, S., Longo,D., Loscalzo, J., Harrison’s
Principles of Internal Medicine, 21st edition. New York: Mc Graw Hill; 2018
8. Jameson, L., Fauci, A., Kasper, D., Hauser, S., Longo,D., Loscalzo, J., Harrison’s
Principles of Internal Medicine, 21st edition. New York: Mc Graw Hill; 2018
I. NEURALLY MEDIATED SYNCOPE
• Final pathway of reflex arc
• Transient change in autonomic
efferent activity
• Premonitory features
Cardiac output
Parasympathetic outflow
9. Jameson, L., Fauci, A., Kasper, D., Hauser, S., Longo,D., Loscalzo, J., Harrison’s
Principles of Internal Medicine, 21st edition. New York: Mc Graw Hill; 2018
• Cornerstone of management
- REASSURANCE
- EDUCATION
- AVOIDANCE
- EXPANSION
• Isometric counterpressure
maneuvers
• Cardiac pacemaker is rarely
beneficial
10. Jameson, L., Fauci, A., Kasper, D., Hauser, S., Longo,D., Loscalzo, J., Harrison’s
Principles of Internal Medicine, 21st edition. New York: Mc Graw Hill; 2018
II. ORTHOSTATIC HYPOTENSION
• Autonomic failure
• Slow decline in pressure
• Non-specific symptoms due to sudden
postural change
• “Synucleinopathies”, Peripheral
neuropathies
Vagal tone
Compensatory tachycardia
11. Jameson, L., Fauci, A., Kasper, D., Hauser, S., Longo,D., Loscalzo, J., Harrison’s
Principles of Internal Medicine, 21st edition. New York: Mc Graw Hill; 2018
• Reduction in SBP of at least 20 mmHg
or DBP of at least 10 mmHg
• Treatment interventions:
- Removal of reversible causes
- Non-pharmacologic
- Pharmacologic (as Midodrine
and l-dihydroxyphenylserine)
- Supplementary agents
(Pyridostigmine, Ocreotide, EPO)
12. Jameson, L., Fauci, A., Kasper, D., Hauser, S., Longo,D., Loscalzo, J., Harrison’s
Principles of Internal Medicine, 21st edition. New York: Mc Graw Hill; 2018
III. CARDIAC SYNCOPE
I. ARRHYTHMIAS
Bradyarrhythmia
• Sinus node dysfunction (tachycardia-
bradycardia syndrome)
• Bradycardia or Asystole (Stokes-
Adams attack)
Ventricular tachyarrhythmia
Inherited channelopathies
13. Jameson, L., Fauci, A., Kasper, D., Hauser, S., Longo,D., Loscalzo, J., Harrison’s
Principles of Internal Medicine, 21st edition. New York: Mc Graw Hill; 2018
II. STRUCTURAL HEART DISEASE
• Vagal overactivity
• Arrhythmogenesis
• Treatment interventions:
- Cardiac pacing
- Anti-arrhythmic drugs
- Cardioverter-defibrillator
- Holter monitoring
19. Jameson, L., Fauci, A., Kasper, D., Hauser, S., Longo,D., Loscalzo, J., Harrison’s
Principles of Internal Medicine, 21st edition. New York: Mc Graw Hill; 2018
21. Rapid eye movement => PERIPHERAL
No eye movement => CENTRAL
HEAD-IMPULSE
NYSTAGMUS
Horizontal => PERIPHERAL
Vertical / torsional => CENTRAL
TEST OF SKEW
Vertical deviation => Abnormal result
Muncie, H.L., Sirmans, S.M., James, E.,Dizziness: Approach to Evaluation and
mnagement. Americal Family Physician 2017; 95(3): 154-162
22. Rapid eye movement => PERIPHERAL
No eye movement => CENTRAL
HEAD-IMPULSE
NYSTAGMUS
Horizontal => PERIPHERAL
Vertical / torsional => CENTRAL
TEST OF SKEW
Vertical deviation => Abnormal result
Muncie, H.L., Sirmans, S.M., James, E.,Dizziness: Approach to Evaluation and
mnagement. Americal Family Physician 2017; 95(3): 154-162
23. Rapid eye movement => PERIPHERAL
No eye movement => CENTRAL
HEAD-IMPULSE
NYSTAGMUS
Horizontal => PERIPHERAL
Vertical / torsional => CENTRAL
TEST OF SKEW
Vertical deviation => Abnormal result
Muncie, H.L., Sirmans, S.M., James, E.,Dizziness: Approach to Evaluation and
mnagement. Americal Family Physician 2017; 95(3): 154-162
24. Rapid eye movement => PERIPHERAL
No eye movement => CENTRAL
HEAD-IMPULSE
NYSTAGMUS
Horizontal => PERIPHERAL
Vertical / torsional => CENTRAL
TEST OF SKEW
Vertical deviation => Abnormal result
Muncie, H.L., Sirmans, S.M., James, E.,Dizziness: Approach to Evaluation and
mnagement. Americal Family Physician 2017; 95(3): 154-162
25. Jameson, L., Fauci, A., Kasper, D., Hauser, S., Longo,D., Loscalzo, J., Harrison’s
Principles of Internal Medicine, 21st edition. New York: Mc Graw Hill; 2018
30. UPPER MOTOR NEURON PATHWAY
• Distal > proximal
• Axial movements are spared UNLESS severe
and bilateral
• Normal rhythmicity, but repetitive movements
• Corticobulbar = lower face and tongue
Muncie,
H.L.,
Sirmans,
S.M.,
James,
E.,Dizziness:
Approach
to
Evaluation
and
mnagement.
Americal
Family
Physician
2017;
95(3):
154-162
Jameson,
L.,
Fauci,
A.,
Kasper,
D.,
Hauser,
S.,
Longo,D.,
Loscalzo,
J.,
Harrison’s
Principles
of
Internal
Medicine,
21st
edition.
New
York:
Mc
Graw
Hill;
2018
31. LOWER MOTOR NEURON PATHWAY
• Decrease in number of muscle fibers
• Absent stretch reflex = spindle afferent
fibers
• Fasciculations vs Fibrillation potentials
• Delayed recruitment of motor units
Muncie,
H.L.,
Sirmans,
S.M.,
James,
E.,Dizziness:
Approach
to
Evaluation
and
mnagement.
Americal
Family
Physician
2017;
95(3):
154-162
Jameson,
L.,
Fauci,
A.,
Kasper,
D.,
Hauser,
S.,
Longo,D.,
Loscalzo,
J.,
Harrison’s
Principles
of
Internal
Medicine,
21st
edition.
New
York:
Mc
Graw
Hill;
2018
36. Jameson, L., Fauci, A., Kasper, D., Hauser, S., Longo,D.,
Loscalzo, J., Harrison’s Principles of Internal Medicine, 21st
edition. New York: Mc Graw Hill; 2018
Muncie, H.L., Sirmans, S.M., James, E.,Dizziness: Approach to
Evaluation and mnagement. Americal Family Physician 2017;
95(3): 154-162
RESOURCES
37. CREDITS: This presentation template was created by
Slidesgo, and includes icons by Flaticon, and
infographics & images by Freepik
THANK YOU FOR LISTENING!
DO YOU HAVE ANY QUESTIONS?
Please keep this slide for attribution